{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-021918","form_type":"8-K","ticker":"SUPN","cik":"0001356576","company_name":"SUPERNUS PHARMACEUTICALS, INC.","filed_at":"2023-02-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:44.598100+00:00","generated_at":"2026-06-19T13:27:25.576309+00:00","sec_items":["1.01","2.03","8.01","9.01"],"event_type":"debt","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Supernus enters into $150M secured credit facility with UBS","bullets":["Up to $150M revolving credit line for general corporate purposes, secured by investment accounts held at UBS.","Borrowings bear interest at UBS Fixed or Variable Funding Rate plus applicable spread.","Uncommitted demand facility; UBS can demand repayment and terminate at any time without cause.","CEO Jack Khattar stated the credit line strengthens balance sheet flexibility."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-021918","json":"https://secwatch.observer/filing/0001104659-23-021918.json","markdown":"https://secwatch.observer/filing/0001104659-23-021918.md","text":"https://secwatch.observer/filing/0001104659-23-021918.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1356576/000110465923021918/0001104659-23-021918-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1356576/000110465923021918/tm235504d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T13:27:25.576309+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"372bfa44b85028d586116b7f5eebb023305ffae0","claim":"SUPERNUS PHARMACEUTICALS, INC. incurred revolving credit of up to $150,000,000.00 with UBS Bank USA at Fixed rate: UBS Fixed Funding Rate + applicable Percentage Spread; Variable rate maturing Not explicitly stated; payable on demand or upon default.","evidence_excerpt":"On February 8, 2023, Supernus Pharmaceuticals, Inc. ( the “Company”) entered into a credit line agreement (the “Credit Line”) with UBS Bank USA (“UBS”). The Credit Line provides for a revolving line of credit of up to $150,000,000.00, which can be drawn at any time and will be used for general corporate purposes.","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465923021918/0001104659-23-021918-index.htm","confidence":0.92,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"revolving credit"},{"label":"Principal","value":"up to $150,000,000.00"},{"label":"Counterparty","value":"UBS Bank USA"},{"label":"Rate","value":"Fixed rate: UBS Fixed Funding Rate + applicable Percentage Spread; Variable rate"},{"label":"Maturity","value":"Not explicitly stated; payable on demand or upon default"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"},{"claim_id":"e78fc9ad3301a775128275ea6dd41bd4009ebce5","claim":"SUPERNUS PHARMACEUTICALS, INC. entered into Credit Line with UBS Bank USA valued at $150,000,000.00 (effective 2023-02-08).","evidence_excerpt":"On February 8, 2023, Supernus Pharmaceuticals, Inc. ( the “Company”) entered into a credit line agreement (the “Credit Line”) with UBS Bank USA (“UBS”). The Credit Line provides for a revolving line of credit of up to $150,000,000.00","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465923021918/0001104659-23-021918-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"credit facility"},{"label":"Counterparty","value":"UBS Bank USA"},{"label":"Value","value":"$150,000,000.00"},{"label":"Effective","value":"2023-02-08"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}